JMP Securities raised the firm’s price target on DraftKings (DKNG) to $60 from $50 and keeps an Outperform rating on the shares. DraftKings ...

JMP Securities analyst Aaron Kimson raised the firm’s price target on Procore (PCOR) to $95 from $90 and keeps an Outperform rating on the ...

JMP Securities maintained a Market Outperform rating and a $41.00 price target for Exelixis (NASDAQ:EXEL) shares, aligning with the broader analyst consensus as five analysts have recently revised ...

JMP Securities restated their market outperform rating on shares of Digital Realty Trust (NYSE:DLR – Free Report) in a ...

At CNBC’s WorldWide Exchange, Zack Kass, an AI futurist and former Head of GTM at OpenAI, discussed the implications of a Chinese firm creating a GPT-4 equivalent model with remarkable efficiency.

As the US stock markets were catching up with the tech disruption led by cheap Chinese AI models, US President Donald Trump’s ...

Fintel reports that on January 2, 2025, JMP Securities downgraded their outlook ... In its prior filing, the firm reported owning 150,552K shares , representing a decrease of 0.04%.

https://www.tipranks.com/news/the-fly/bio-rad-price-target-lowered-to-447-from-477-at-rbc-capital JMP Securities analyst Constantine Davides raised the firm’s price ...

Fintel reports that on January 2, 2025, JMP Securities downgraded their outlook ... In its prior filing, the firm reported owning 150,552K shares , representing a decrease of 0.04%.

JMP Securities reissued their market outperform rating on shares of CureVac (NASDAQ:CVAC – Free Report) in a report published on Friday,Benzinga reports. JMP Securities currently has a $16.00 price ...